Drug intelligence / Profile preview

Easy Transil FAST

Development stage: Unknown
Lead developer: Astel Medica
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Easy Transil FAST is a multi-ingredient dietary supplement developed by Astel Medica to support regular intestinal transit and manage constipation. The formulation contains a blend of botanical extracts, fibers, and probiotics. Specifically, it includes *Cassia italica* (Senna) to help maintain regularity, *Terminalia chebula* to promote normal stools, and algae to lubricate the food bolus. Additionally, oat fiber increases the volume of the food bolus, while beneficial bacteria (probiotics) support the gut microbiota. It is an oral capsule intended for adults and children over 12, and is formulated to be lactose-free, gluten-free, and soy-free.

Brand names: Easy Transil FAST

Beyond the preview

Go deeper on Easy Transil FAST.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Easy Transil FAST.

Explore the full profile